Search

The article focuses on the latest NICE guideline aimed at increasing the number of patients offered statins to reduce cardiovascular risk, discussing detection methods, initiating statin therapy, and optimizing treatment for both primary and secondary prevention of cardiovascular disease (CVD). It emphasizes the importance of systematic risk assessment using tools like QRISK3, baseline tests before initiating statin therapy, and considerations for treatment escalation.

The article discusses various issues concerning lipid modification in relation to cardiovascular disease (CVD). It cites the guidance on lipid modification published by Great Britain National Institute for Clinical Excellence (NICE). An explanation on the value of lipid modification in the primary prevention of CVD is offered, along with the factors that affect cholesterol measurement. The article also discusses the pharmacological management of CVD.

The article focuses on a new agenda adopted by the Great Britain Department of Health (DH) that offers health professionals working with patients at high cardiovascular risk and their families the opportunity to put prevention first. The lipid guideline advises on lifestyle and medical modification of lipids in patients with atherosclerotic cardiovascular disease and in those who are at high risk of developing disease. The guideline also recommends that health professionals should focus on total or absolute risk when explaining risk to patients.

Discusses the management of type 2 diabetes. Role of lipids in cardiovascular disease; Identification of patients with type 2 diabetes; Treatment; Risk factors for diabetes; Information on dyslipidaemia.

The article focuses on the use of diet to help reduce lipid levels. Hyperlipidaemia is a major risk factor for cardiovascular disease, such as ischaemic stroke. Dietary modification is the cornerstone of lifestyle strategies that aim to reduce lipid levels. However, the maximum reduction in total cholesterol that most individuals will achieve by following a low fat diet and losing weight is 3 to 6 percent. This suggests a need to look beyond modifying the amount and type of fat in the diet.

The article reports that practice nurses in Great Britain will be expected to hit tough new targets on the identification of people at risk of cardiovascular disease (CVD) and for lipid modification, following the publication of new guidance from the National Institute for Clinical Excellence (NICE). NICE says that practices must adopt a more systematic strategy to identify people who are likely to be at high risk of CVD.